Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 3/20 | 0.32 |
| ▸ | CDK8 | P49336 | 3/20 | 0.32 |
| ▸ | HASPIN | Q8TF76 | 3/20 | 0.32 |
| ▸ | CDK19 | Q9BWU1 | 2/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27244751 | 0.89 | CCNC (0.34) | CCNCCDK8HASPINCDK19BACE1 | |
| SCHEMBL27245165 | 0.76 | L3MBTL1 (0.35) | GRM2GRM3CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL27245180 | 0.73 | GAA (0.35) | GRM2GRM3CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL27245043 | 0.72 | BACE1 (0.39) | ALDH1A1MAPTHSD17B10BACE1 | |
| Hydrochloric Acid SCHEMBL27245163 | 0.71 | BACE1 (0.39) | ALDH1A1MAPTHSD17B10BACE1 | |
| SCHEMBL27244874 | 0.70 | IMPDH2 (0.35) | CCNCCDK8HASPIN | |
| SCHEMBL27245044 | 0.68 | AKR1B1 (0.42) | ALDH1A1KDM4E | |
| Hydrochloric Acid SCHEMBL30890769 | 0.68 | AKR1B1 (0.41) | ALDH1A1KDM4E | |
| SCHEMBL1191378 | 0.66 | KDM4E (0.44) | CCNCCDK8HASPINCDK19ALDH1A1 | |
| SCHEMBL30890459 | 0.65 | AAK1 (0.34) | CCNCCDK8HASPIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |